Darefsky AS, King JT Jr, Dubrow R (2012) Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of surveillance, epidemiology, and end results registries. Cancer 118:2163–2172. https://doi.org/10.1002/cncr.26494

Article  PubMed  Google Scholar 

Ho VKY, Reijneveld JC, Enting RH, Bienfait HP, Robe P, Baumert BG, Visser O (2014) Changing incidence and improved survival of gliomas. Eur J Cancer 50:2309–2318. https://doi.org/10.1016/j.ejca.2014.05.019

Article  PubMed  Google Scholar 

Koekkoek JAF, van der Meer PB, Pace A, Hertler C, Harrison R, Leeper HE, Forst DA, Jalali R, Oliver K, Philip J, Taphoorn MJB, Dirven L, Walbert T (2022) Palliative care and end-of-life care in adults with malignant brain tumors. Neuro Oncol 25:447–456. https://doi.org/10.1093/neuonc/noac216

Article  PubMed Central  Google Scholar 

van der Meer PB, Taphoorn MJB, Koekkoek JAF (2022) Management of epilepsy in brain tumor patients. Curr Opin Oncol 34:685–690

Article  PubMed  PubMed Central  Google Scholar 

Posti JP, Bori M, Kauko T, Sankinen M, Nordberg J, Rahi M, Frantzén J, Vuorinen V, Sipilä JO (2015) Presenting symptoms of glioma in adults. Acta Neurol Scand 131:88–93. https://doi.org/10.1111/ane.12285

Article  PubMed  CAS  Google Scholar 

Rasmussen BK, Hansen S, Laursen RJ, Kosteljanetz M, Schultz H, Nørgård BM, Guldberg R, Gradel KO (2017) Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I-IV in the the Danish Neuro-Oncology Registry. J Neurooncol 135:571–579. https://doi.org/10.1007/s11060-017-2607-5

Article  PubMed  Google Scholar 

Rooney AG, Carson A, Grant R (2011) Depression in cerebral glioma patients: a systematic review of observational studies. J Natl Cancer Inst 103:61–76. https://doi.org/10.1093/jnci/djq458

Article  PubMed  Google Scholar 

Huang J, Zeng C, Xiao J, Zhao D, Tang H, Wu H, Chen J (2017) Association between depression and brain tumor: a systematic review and meta-analysis. Oncotarget 8:94932–94943. https://doi.org/10.18632/oncotarget.19843

Article  PubMed  PubMed Central  Google Scholar 

Boele FW, Rooney AG, Grant R, Klein M (2015) Psychiatric symptoms in glioma patients: from diagnosis to management. Neuropsychiatr Dis Treat 11:1413–1420. https://doi.org/10.2147/ndt.S65874

Article  PubMed  PubMed Central  Google Scholar 

Regli LKP, Huijs SMH, Pasmans RCOS, Leue C, Dijkstra JB, Eekers DBP, Hovinga KE, Anten MHME, Hoeben A, Broen MPG (2023) Incidence of clinically relevant psychiatric symptoms during glioblastoma treatment: an exploratory study. J Neurooncol 163:185–194. https://doi.org/10.1007/s11060-023-04326-2

Article  PubMed  PubMed Central  CAS  Google Scholar 

Samudra N, Zacharias T, Plitt A, Lega B, Pan E (2019) Seizures in glioma patients: an overview of incidence, etiology, and therapies. J Neurol Sci 404:80–85. https://doi.org/10.1016/j.jns.2019.07.026

Article  PubMed  Google Scholar 

Rydén I, Thurin E, Carstam L, Smits A, Gulati S, Henriksson R, Salvesen Ø, Store Jakola A (2021) Psychotropic and anti-epileptic drug use, before and after surgery, among patients with low-grade glioma: a nationwide matched cohort study. BMC Cancer 21:248. https://doi.org/10.1186/s12885-021-07939-w

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gramatzki D, Rogers JL, Neidert MC, Hertler C, Le Rhun E, Roth P, Weller M (2020) Antidepressant drug use in glioblastoma patients: an epidemiological view. Neurooncol Pract 7:514–521. https://doi.org/10.1093/nop/npaa022

Article  PubMed  PubMed Central  Google Scholar 

Knudsen-Baas KM, Johannesen TB, Myklebust TÅ, Aarseth JH, Owe JF, Gilhus NE, Storstein AM (2018) Antiepileptic and psychiatric medication in a nationwide cohort of patients with glioma WHO grade II-IV. J Neurooncol 140:739–748. https://doi.org/10.1007/s11060-018-03007-9

Article  PubMed  CAS  Google Scholar 

Jacob JR, Palanichamy K, Chakravarti A (2024) Antipsychotics possess anti-glioblastoma activity by disrupting lysosomal function and inhibiting oncogenic signaling by stabilizing PTEN. Cell Death Dis 15:414. https://doi.org/10.1038/s41419-024-06779-3

Article  PubMed  PubMed Central  CAS  Google Scholar 

Stella M, Baiardi G, Pasquariello S, Sacco F, Dellacasagrande I, Corsaro A, Mattioli F, Barbieri F (2023) Antitumor potential of antiepileptic drugs in human glioblastoma: pharmacological targets and clinical benefits. Biomedicines. https://doi.org/10.3390/biomedicines11020582

Article  PubMed  PubMed Central  Google Scholar 

Abadi B, Shahsavani Y, Faramarzpour M, Rezaei N, Rahimi HR (2022) Antidepressants with anti-tumor potential in treating glioblastoma: a narrative review. Fundam Clin Pharmacol 36:35–48. https://doi.org/10.1111/fcp.12712

Article  PubMed  CAS  Google Scholar 

Pottegård A, Hallas J (2017) New use of prescription drugs prior to a cancer diagnosis. Pharmacoepidemiol Drug Saf 26:223–227. https://doi.org/10.1002/pds.4145

Article  PubMed  Google Scholar 

Laugesen K, Ludvigsson JF, Schmidt M, Gissler M, Valdimarsdottir UA, Lunde A, Sørensen HT (2021) Nordic health registry-based research: a review of health care systems and key registries. Clin Epidemiol 13:533–554. https://doi.org/10.2147/clep.S314959

Article  PubMed  PubMed Central  Google Scholar 

Ford DV, Jones KH, Verplancke JP, Lyons RA, John G, Brown G, Brooks CJ, Thompson S, Bodger O, Couch T, Leake K (2009) The SAIL Databank: building a national architecture for e-health research and evaluation. BMC Health Serv Res 9:157. https://doi.org/10.1186/1472-6963-9-157

Article  PubMed  PubMed Central  Google Scholar 

Jones K, Ford D, Lyons R (2017) The SAIL databank: 10 years of spearheading data privacy and research utility, 2007–2017. Swansea University, Swansea. https://doi.org/10.23889/sail-databank.1001101

Book  Google Scholar 

Lyons RA, Jones KH, John G, Brooks CJ, Verplancke J-P, Ford DV, Brown G, Leake K (2009) The SAIL databank: linking multiple health and social care datasets. BMC Med Inform Decis Mak 9:3. https://doi.org/10.1186/1472-6947-9-3

Article  PubMed  PubMed Central  Google Scholar 

WHO Collaborating Centre for Drug Statistics Methodology (2024) Guidelines for ATC classification and DDD assignment 2024. WHO, Oslo

Google Scholar 

Booth N (1994) What are the read codes? Health Libr Rev 11:177–182. https://doi.org/10.1046/j.1365-2532.1994.1130177.x

Article  PubMed  CAS  Google Scholar 

Rothman KJ, Greenland S, Lash TL (2008) Modern epidemiology. Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia

Google Scholar 

Bojanić I (2024) Use of antidepressant and anxiolytic drugs in Scandinavian Countries between 2006 and 2021: a prescription database study. Depress Anxiety 2024:5448587. https://doi.org/10.1155/2024/5448587

Article  PubMed Central  Google Scholar 

Archer C, MacNeill SJ, Mars B, Turner K, Kessler D, Wiles N (2022) Rise in prescribing for anxiety in UK primary care between 2003 and 2018: a population-based cohort study using clinical practice research datalink. Br J Gen Pract 72:e511–e518. https://doi.org/10.3399/bjgp.2021.0561

Article  PubMed  PubMed Central  Google Scholar 

Hauff NS, Storstein A (2023) Seizure management and prophylaxis considerations in patients with brain tumors. Curr Oncol Rep 25:787–792. https://doi.org/10.1007/s11912-023-01410-8

Article  PubMed  PubMed Central  Google Scholar 

Armstrong TS, Shade MY, Breton G, Gilbert MR, Mahajan A, Scheurer ME, Vera E, Berger AM (2017) Sleep-wake disturbance in patients with brain tumors. Neuro Oncol 19:323–335. https://doi.org/10.1093/neuonc/now119

Article  PubMed  Google Scholar 

van der Meer PB, Dirven L, Hertler C, Boele FW, Batalla A, Walbert T, Rooney AG, Koekkoek JAF (2023) Depression and anxiety in glioma patients. Neurooncol Pract 10:335–343. https://doi.org/10.1093/nop/npad019

Article  PubMed